Aileron Therapeutics, Inc. (ALRN) Social Stream



Aileron Therapeutics, Inc. (ALRN): $1.24

-0.02 (-1.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALRN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 474

in industry

AILERON THERAPEUTICS INC (ALRN) Price Targets From Analysts

Use the tables below to see what analysts covering AILERON THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 1 $2 $2 $2 $1.28 56.25%
2022-05-09 2 $2 $2 $2 $1.28 56.25%
2022-06-14 3 $2 $2 $2 $1.28 56.25%
2022-06-30 3 $2 $1 $1.5 $1.28 17.19%
2022-08-16 3 $2 $1 $1.5 $1.28 17.19%
2022-11-02 3 $40 $40 $40 $1.28 3025%
NA 2 $NA $NA $NA $1.28 NA%

The Trend in the Analyst Price Target


ALRN's average price target has moved down $1.5 over the prior 18 months.

Over the past 177 days, ALRN's average upside potential has been 3,347.57%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-30 3 2 1 1.5 0.260 476.92%
2022-08-16 3 2 2 2.0 0.220 809.09%
2022-08-16 3 2 1 1.5 0.220 581.82%
2022-11-02 3 40 40 40.0 3.964 909.08%
2022-11-02 3 2 2 2.0 3.964 -49.55%

ALRN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 1 0 2 0 0 3

The Trend in the Broker Recommendations


Over the past 13 months, ALRN's average broker recommendation rating worsened by 0.66.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALRN as an investment opportunity.

  • AILERON THERAPEUTICS INC's number of analysts covering the stock is greater than 35.61% of all US stocks.
  • In terms of how AILERON THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than 26.79% of that group.
  • In terms of how AILERON THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its average analyst price target is higher than 203.85% of that group.
  • AILERON THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 266.24% of stocks in the micro market cap category.

In the Pharmaceutical Products industry, CAPR, KTRA, and ATXI are the three stocks most similar to AILERON THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ALRN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6786 seconds.